Nuveen Asset Management’s Lexicon Pharmaceuticals LXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
$815K Hold
1,103,840
﹤0.01% 2792
2024
Q3
$1.73M Buy
1,103,840
+887,574
+410% +$1.39M ﹤0.01% 2489
2024
Q2
$363K Sell
216,266
-307,911
-59% -$517K ﹤0.01% 3097
2024
Q1
$1.26M Buy
524,177
+113,131
+28% +$272K ﹤0.01% 2602
2023
Q4
$629K Buy
411,046
+1,867
+0.5% +$2.86K ﹤0.01% 2931
2023
Q3
$446K Buy
409,179
+89,985
+28% +$98.1K ﹤0.01% 2878
2023
Q2
$731K Buy
319,194
+117,680
+58% +$269K ﹤0.01% 2784
2023
Q1
$489K Sell
201,514
-43,136
-18% -$105K ﹤0.01% 2812
2022
Q4
$467K Sell
244,650
-61,866
-20% -$118K ﹤0.01% 2900
2022
Q3
$736K Buy
306,516
+56,582
+23% +$136K ﹤0.01% 2862
2022
Q2
$465K Buy
249,934
+6,054
+2% +$11.3K ﹤0.01% 3037
2022
Q1
$530K Buy
243,880
+1,527
+0.6% +$3.32K ﹤0.01% 2994
2021
Q4
$904K Sell
242,353
-340,947
-58% -$1.27M ﹤0.01% 2891
2021
Q3
$2.83M Sell
583,300
-85,183
-13% -$414K ﹤0.01% 2511
2021
Q2
$3.07M Buy
668,483
+222,456
+50% +$1.02M ﹤0.01% 2502
2021
Q1
$2.62M Buy
446,027
+233,728
+110% +$1.37M ﹤0.01% 2490
2020
Q4
$726K Buy
212,299
+11,415
+6% +$39K ﹤0.01% 2918
2020
Q3
$289K Hold
200,884
﹤0.01% 3098
2020
Q2
$401K Buy
200,884
+30,367
+18% +$60.6K ﹤0.01% 2975
2020
Q1
$332K Buy
170,517
+11,891
+7% +$23.2K ﹤0.01% 2897
2019
Q4
$658K Sell
158,626
-15,081
-9% -$62.6K ﹤0.01% 2833
2019
Q3
$522K Sell
173,707
-8,496
-5% -$25.5K ﹤0.01% 2933
2019
Q2
$1.15M Buy
+182,203
New +$1.15M ﹤0.01% 2677
2015
Q2
Sell
-2,532
Closed -$17K 1523
2015
Q1
$17K Sell
2,532
-5,235
-67% -$35.1K ﹤0.01% 1494
2014
Q4
$49K Sell
7,767
-174
-2% -$1.1K ﹤0.01% 1511
2014
Q3
$78K Hold
7,941
﹤0.01% 1473
2014
Q2
$89K Hold
7,941
﹤0.01% 1503
2014
Q1
$96K Hold
7,941
﹤0.01% 1490
2013
Q4
$100K Buy
7,941
+196
+3% +$2.47K ﹤0.01% 1446
2013
Q3
$129K Buy
7,745
+171
+2% +$2.85K ﹤0.01% 1337
2013
Q2
$115K Buy
+7,574
New +$115K ﹤0.01% 1415